These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15726606)

  • 21. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.
    Fillit H; Hess G; Hill J; Bonnet P; Toso C
    Neurology; 2009 Jul; 73(3):180-5. PubMed ID: 19620605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong.
    Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Wong KS
    Cerebrovasc Dis; 2009; 28(2):112-8. PubMed ID: 19506369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus-related polyneuropathy: case report and review of the literature.
    De Weerdt A; Claeys KG; De Jonghe P; Ysebaert D; Chapelle T; Roeyen G; Jorens PG
    Clin Neurol Neurosurg; 2008 Mar; 110(3):291-4. PubMed ID: 18055100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy.
    Tackenberg B; Lünemann JD; Steinbrecher A; Rothenfusser-Korber E; Sailer M; Brück W; Schock S; Zschenderlein R; Zipp F; Sommer N
    Neurology; 2007 May; 68(19):1622-9. PubMed ID: 17485651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    Doss-Esper CE; Singhal AB; Smith MS; Henderson GV
    J Neuroimaging; 2005 Apr; 15(2):188-92. PubMed ID: 15746232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):38-42. PubMed ID: 7964851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Seow H; Wilson P
    J Peripher Nerv Syst; 2006 Dec; 11(4):325-9. PubMed ID: 17117941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
    Rentzos M; Anyfanti C; Kaponi A; Pandis D; Ioannou M; Vassilopoulos D
    J Clin Neurosci; 2007 Mar; 14(3):229-35. PubMed ID: 17258131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
    Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
    Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.
    Vermeulen M; van Doorn PA; Brand A; Strengers PF; Jennekens FG; Busch HF
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):36-9. PubMed ID: 8429321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
    Hergüner MO; Incecik F; Altunbaşak S
    Pediatr Neurol; 2009 Sep; 41(3):223-5. PubMed ID: 19664543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
    Harbo T; Andersen H; Jakobsen J
    Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.
    Cats EA; van der Pol WL; Piepers S; Notermans NC; van den Berg-Vos RM; van den Berg LH
    J Neurol; 2008 Oct; 255(10):1598-9. PubMed ID: 18758888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.